ALIT Archives

ALIT

Letters With This Ticker

Quarter	Letter Date	Fund Name	QTD	YTD	Tickers	Keywords/Themes	Theme Commentary	Pitches	Letter
2024 Q2	Aug 6, 2024	Greenlight Capital	1.1%	9.0%	ALIT, BHF, CEIX, CPRI, FCNCA, GPOR, HPQ, KD, ODP, ONEX.TO, SOLB.BR	energy, gold, Long/Short, Macro, technology, value	Gold continued its strong year-to-date performance and was a material contributor to the macro book this quarter, generating more than one percent return.	CPRI SOLB.BR KD HPQ CEIX	View
2025 Q2	Aug 2, 2025	Meridian Small Cap Growth Fund	6.9%	-	ALIT, AXGN, CARG, CCSI, FSS, KEX, MIR, NTIC, PACK, RELY, SPT, TPB, VNOM	energy, growth, healthcare, nuclear, Quality, Resilience, small caps	The fund focuses exclusively on small-cap growth companies, with the Russell 2000 Growth Index as its benchmark. Small caps returned 8.5% in the quarter, recovering 24.0% from April lows, with growth stocks outperforming value stocks significantly.	NPKI TPB MIR VNOM AXGN RANP VNOM AXGN PACK	View
2025 Q2	Jul 22, 2025	Aristotle Small Cap Equity Fund	3.3%	-	ACIW, AEIS, ALIT, BHLB, CHE, CMCO, DY, FLS, GRDN, HURN, IPAR, ITRI, JBGS, LQDT, MMSI, MNRO, MTSI, SMG, TKO, VRRM	growth, healthcare, industrials, small caps, technology, Telecommunications, value	Valuations remain compelling relative to large caps, with the Russell 2000 Index trading near multi-decade lows on a relative basis. Potential tailwinds include deregulation, lower corporate tax rate, increased M&A activity, continued reshoring of U.S. manufacturing, and infrastructure-related spending.	VRRM SMG IPAR GRDN FLS ALIT ACIW CHE MTSI DY CHE	View
2025 Q2	Jul 22, 2025	Aristotle Small/Mid Cap Equity	4.6%	-	ACIW, AENE, ALIT, ASGN, BHLB, CHE, CIEN, CMCO, DLB, DY, FTAI, HOOD, IPAR, ITRI, JBGS, MMSI, MTSI, PRGO, SMG, VRRM	growth, industrials, positioning, SMID Cap, technology, value, volatility	MACOM Technology Solutions benefited from exposure to growing demand from Data Center and 5G end market applications. The company surpassed analyst expectations and raised forward guidance, with meaningful exposure to these growing markets along with domestic manufacturing footprint expected to drive additional shareholder value.	VRRM SMG PRGO IPAR FTAI DLB ALIT CHE ACIW MTSI DY CHE	View
2026 Q1	May 1, 2026	Aristotle Small/Mid Cap Equity	2.3%	2.3%	AEIS, ALIT, CIEN, CWST, HURN, NVST	AI, domestic, energy, Manufacturing, semiconductors, small caps, technology, value		NVST CWST HURN CIEN AEIS	View
2024 Q1	Apr 15, 2024	Meridian Growth Fund	6.8%	0.0%	ACVA, ALIT, CARG, EEFT, IRDM, MATX, QDEL, RBA, SHC, ST, STE, TRMB, ZD	growth, Quality, Recurring Revenue, risk management, small caps, technology	QuidelOrtho Corporation is a global leader in the diagnostics industry following the merger of Quidel and Ortho Clinical Diagnostics. The company faced challenges from a dramatic slowdown in Covid-19 testing volumes but maintains steady performance in its core clinical diagnostic division with EBITDA margins north of 20%.	RBA ACVA TRMB SHC IRDM QDEL	View
2024 Q1	Apr 15, 2024	Meridian Small Cap Growth Fund	6.2%	0.0%	ACVA, ALIT, BYRN, CARG, CNCL, FORR, LZ, MATX, MIR, MMSI, NRGN, QDEL, RBA, SG, STNE, TPB	Automation, Diagnostics, growth, healthcare, small cap, technology	The fund holds multiple healthcare positions including QuidelOrtho Corporation in diagnostics, Consensus Cloud Solutions serving healthcare data security, and Neurogene in gene therapy. Healthcare IT staffing issues are creating macro pressure on enterprise-level adoptions.	SG NRGN BYRN FORR QDEL CNCL	View
2025 Q1	Mar 31, 2025	Meridian Growth Fund	-8.0%	-8.0%	ALIT, CARG, CHDN, COO, EEFT, HALO, OKTA, RBA, STE, TNDM, TRMB, WAY, ZD	Biotechnology, cybersecurity, growth, healthcare, Quality, Resilience, small caps, tariffs	The fund focuses on small-cap growth investing through the Russell 2500 Growth Index benchmark, with emphasis on high-quality businesses with recurring revenue and sustainable competitive advantages. The strategy demonstrated resilience during the quarter's market decline, outperforming on six of seven days when the index declined 2% or more.	CARG TNDM ZD RBA HALO OKTA	View
2025 Q1	Mar 31, 2025	Meridian Small Cap Growth Fund	-12.2%	-12.2%	ALIT, CARG, CSOD, IMXI, LZ, MMSI, RBA, TNDM, TPB, VCYT, VNOM, WAY	Diagnostics, growth, healthcare, Medical Devices, small caps, tariffs, Trade Policy, volatility	The fund focuses exclusively on small-cap growth stocks, with the Russell 2000 Growth Index as its benchmark. Small-cap stocks fell more sharply than large-caps during the quarter, declining 9.5% versus 4.5% for large-caps. The strategy's emphasis on smaller cap stocks within the index was a headwind during the quarter as larger-cap stocks outperformed.	MMSI RBA LZ VCYT IMXI TNDM	View
2024 Q4	Feb 10, 2025	Meridian Growth Fund	-0.8%	6.3%	ALIT, CARG, CHDN, DOCS, EEFT, GNRC, OKTA, RBA, RELY, ST, STE, TMDX, TRMB, ZD	growth, healthcare, industrials, Quality, small caps, technology	The portfolio's largest allocation with historically attractive valuations below long-term averages. Utilization has recovered above pre-pandemic levels and investor interest in biotechnology is showing signs of revival.	CARG RELY DOCS STE ST TMDX	View
2024 Q4	Feb 10, 2025	Meridian Small Cap Growth Fund	2.8%	11.7%	AGS, ALIT, ANGI, BYRN, CARG, CCSI, MIR, RBA, SMAR, STNE, TMDX, TPB, WAY	growth, healthcare, nuclear, Quality, risk management, small caps, technology	Mirion Technologies operates in industries with strong secular trends tied to rising demand for nuclear power, including AI-related data center energy needs. The company provides critical technologies for the nuclear power sector with recurring revenues.	ANGI SRI TMDX BYRN TPB MRAD	View
2023 Q4	Dec 31, 2023	Meridian Growth Fund	6.8%	0.0%	ALIT, CARG, CHDN, EEFT, FOXF, GOOS, HSIC, MATX, RBA, ST, STE, TRMB, ZD	growth, industrials, Quality, small caps, technology	The Fund's investment approach focuses on high-quality companies with recurring revenue and sustainable competitive advantages. The strategy emphasizes building an enduring portfolio that can mitigate capital losses during turbulent bear market environments.	MATX EEFT CARG HSIC FOXF GOOS.TO	View
2023 Q4	Dec 31, 2023	Meridian Small Cap Growth Fund	6.2%	0.0%	ALIT, CARG, CCCC, CCSI, EVRI, HDSN, MATX, MIR, QDEL, RBA, SKIN, SONX, TPB	Biotechnology, gaming, growth, healthcare, small cap, technology, value	The fund holds C4 Therapeutics, a biotechnology firm specializing in protein degradation therapies for cancer treatment. The company has three treatments in early-stage clinical trials targeting multiple cancers and announced a formal agreement with Merck for co-development. Positive clinical readout on a leading compound provided encouraging signals for therapeutic efficacy.	CCCC CARG MRAD	View
2025 Q3	Oct 24, 2025	Meridian Growth Fund	-1.8%	-	ALGN, ALIT, ALKT, CARG, CHDN, COO, DT, GFS, HALO, MDGL, RELY, SPT, STE, TRMB, ZD	AI, growth, healthcare, industrials, Quality, small caps, SMID, technology	The fund sees signs of exuberance and speculative behavior in AI infrastructure ecosystem, particularly in technology and industrial sectors. While AI remains transformative long-term, valuations have become disconnected from fundamentals with companies exceeding $10 billion market caps lacking profits or revenues. The fund remains disciplined and unlikely to pursue high-momentum AI names without meaningful revenues or profitability.	ZD HALO MDGL ALGN SPT ALIT	View
2025 Q3	Oct 24, 2025	Meridian Small Cap Growth Fund	4.2%	-	ALIT, ALKT, AMPL, CARG, CCSI, CERT, KEX, RELY, SPT, TPB, VCYT, VNOM, ZENA	AI, growth, healthcare, industrials, Quality, small caps, technology, Valuations	The fund sees signs of exuberance and speculative behavior in AI infrastructure ecosystem, particularly in technology and industrial sectors. Many companies are trading at historically elevated valuations despite being potential one-time beneficiaries of the AI investment cycle. The fund remains disciplined and avoids high-momentum AI names lacking meaningful revenues or profitability.	CCSI ZENAS TPB KEX SPT ALIT ZD HALO MDGL ALGN SPT CCSI KEX SPT	View
2024 Q3	Oct 23, 2024	Polen Capital – U.S. Small Company Growth	7.4%	-0.9%	AIT, ALIT, ALRM, APPF, BROS, DOCS, ELF, GSHD, HL, IBP, NSIT, NVEE, PCTY, PGNY, RGEN, RH, RMBS, ROAD, RVLV, SITM	growth, healthcare, Quality, small cap, technology, volatility	The fund focuses exclusively on U.S. small cap growth companies, noting that high-quality small cap companies have great latent potential for growth and are trading at significantly below-average valuations. The managers believe the highest quality small cap companies are more likely to take advantage of strong balance sheets and reinvestment to enhance their competitive position.		View
2023 Q3	Oct 19, 2023	Polen Capital – Global SMID Company Growth	7.4%	-2.4%	0696.HK, ALIT, CCCS, DOXY, FIVE, GSHD, MORN, PGNY, XPEL, YETI	Automotive, global, growth, healthcare, insurance, SMID Cap, technology	Goosehead Insurance delivered robust results with 31% revenue growth and 36% premium increases, continuing to execute its plan to clean up corporate organization and return to pre-COVID productivity metrics. The company benefits from strong broker upgrades and S&P Small Cap Index inclusion.	XPEL PGNY MORN 0696.HK AMDOCS FIVE ALIT CCCS YETI GSHD	View
2023 Q3	Oct 19, 2023	Polen Capital – U.S. Small Company Growth	7.4%	-0.9%	ALIT, ALTR, CCCS, CWA, DCGO, DOCS, EEFT, EXL, FTCH, GSHD, LESL, OLO, XPEL, YETI	growth, insurance, Quality, small caps, software, technology	Small cap companies as an asset class are heavily discounted relative to history, presenting attractive opportunities regarding valuation and the prospect of persistent growth. High quality small cap companies have greater latent potential for growth relative to more mature businesses and can quickly reduce spending and increase profitability if needed.	EXLS XPEL CLWD ALIT AMDOCS EEFT YETI CCCS GSHD	View
2024 Q3	Oct 18, 2024	Polen Capital – U.S. SMID Company Growth	8.8%	-1.3%	AIT, ALIT, BAH, BLD, CWAN, DOCS, ELF, FIVE, GSHD, HLNE, MKTX, MPWR, PGNY, POOL, REVL, RGEN, RH, SITM, TTEK, TYL	Concentration, earnings, growth, Quality, SMID Cap, value, volatility	elf Beauty represents a discount beauty company focused on cosmetics and skincare with impressive track record for growth, margins, and returns on capital. The company is uniquely positioned due to its reputation for quality, innovation, and prices well below other mass cosmetics brands, with significant room for growth in brand awareness, shelf space expansion, and international markets.	BAH AIT BLD ELF PGNY HLNE RVLV GSHD	View
2024 Q3	Oct 18, 2024	Polen Capital – Global SMID Company Growth	7.4%	-2.4%	8112.HK, ALIT, BLD, CWAN, ELF, EXLS, FEVR.L, FIVE, GSHD, KNSL, MPWR, PGNY, REVG, TECH, TME, TTEK	global, growth, portfolio, Quality, SMID Cap	Polen focuses on high-quality companies with solid fundamentals, competitive advantages, and strong business models. The managers emphasize their disciplined approach to selecting companies that meet high hurdles for growth and returns. They maintain conviction in their quality growth-oriented portfolio despite recent volatility.		View
2024 Q3	Sep 30, 2024	Diamond Hill Small Cap Fund	8.5%	12.2%	ALIT, ASH, ASTH, CIVI, DEI, ENOV, FA, FTAI, IGIC, JLL, LOB, NSP, PAL, PESI, RMNI, USLM	financials, healthcare, industrials, rates, small caps, value	The fund focuses exclusively on small-cap investments, typically companies with market capitalization below $3 billion or within the Russell 2000 Index range. Small-cap stocks outperformed in Q3, with the Russell 2000 Index gaining 9% and value stocks outperforming growth. The manager continues finding compelling new ideas in the small-cap space despite the ongoing bull market.		View
2023 Q3	Sep 30, 2023	Meridian Small Cap Growth Fund	6.2%	0.0%	ALIT, ALKT, CCCS, HCCI, HDSN, MATX, MIR, QDEL, RBA, TPB	growth, healthcare, industrials, small caps, technology			View
2024 Q2	Jul 24, 2024	Polen Capital – Global SMID Company Growth	7.4%	-2.4%	0700.HK, 4480.T, ALIT, BMBL, CWAN, DATA.L, DLO, FIVE, MPWR, PAYC, PGNY, PME.AX, RVLV, TECH	AI, global, healthcare, quality growth, semiconductors, SMID Cap, technology, volatility	The letter discusses AI beneficiaries experiencing considerable hype and crowding, with Monolithic Power Systems specifically benefiting from AI-driven cloud-based CPU server applications in its enterprise data segment. The company saw compelling fundamentals largely due to growth in enterprise data driven by AI applications.	4480.T DATA.L ALIT PGNY DLO MPWR PME.AX TME	View
2024 Q2	Jul 24, 2024	Polen Capital – U.S. Small Company Growth	7.4%	-0.9%	AAON, AIT, ALIT, APPF, BL, CCCS, DAVA, DOXI, HELE, HLNE, IBP, OPCH, PGNY, RGEN, RH, ROAD, RVLV, SITM, SMCI, WING, WRBY, XPEL	growth, healthcare, Quality, rates, small caps, technology, volatility	The performance gap between small caps and large caps continued to widen during Q2, with small cap investors retreating to lower-volatility sectors. Small cap continues to be highly sensitive to shifting rate expectations, while leadership in large cap remains narrow and driven by momentum.		View
2024 Q2	Jun 30, 2024	Meridian Growth Fund	6.8%	0.0%	ACVA, AGIO, ALIT, CARG, CHDN, CHWY, EEFT, RBA, RELY, SMAR, ST, STE, TMDX, TRMB, ZD	consumer discretionary, growth, healthcare, industrials, Quality, small cap, technology	The fund holds Transmedics Group, a medical technology company with a differentiated capability to facilitate organ transplants through their Organ Care System (OCS). The company reported increased adoption and buildout of its OCS platform with strong top-line growth and profitability metrics ahead of plan.	RELY TRMB ALIT AGIO CHWY TMDX	View
2024 Q2	Jun 30, 2024	Meridian Small Cap Growth Fund	6.2%	0.0%	ACVA, AGS, ALIT, BYRN, CARG, LZ, MIR, MMSI, RBA, SILK, SMAR, STNE, TMDX, TPB	downside protection, growth, Medical Devices, Quality, small caps, technology	The fund holds multiple medical technology companies including TransMedics Group with their revolutionary organ transplant technology and Silk Road Medical with their minimally invasive carotid artery treatment. These companies are taking market share with innovative solutions that improve patient outcomes.	AGS SILK TMDX ALIT BYRN LZ	View
2024 Q4	Jan 23, 2025	Polen Capital – Global SMID Company Growth	7.4%	-2.4%	8112.T, ALIT, BLD, CWAN, ELF, EXLS, FEVR.L, FIVE, GSHD, KNSL, MPWR, PGNY, REVG, TECH, TME, TTEK	global, growth, Quality, SMID Cap, underperformance, volatility	Initiated position in elf Beauty, a cosmetics company with reputation for quality and innovation at considerably lower prices than other mass cosmetics brands. The company has robust growth potential with low brand awareness, expanding shelf space, growing product portfolio, and early international expansion opportunities.		View
2023 Q4	Jan 22, 2024	Greenlight Capital	1.1%	9.0%	ALIT, ATVI, BHF, CEIX, GRBK, KD, SWN, SYENS.BR, THC, VTRS, VTSC.DE	Buybacks, energy, Geopolitical, healthcare, Long/Short, technology, value	Greenlight emphasizes disciplined valuation criteria and investments where they get paid by issuers through buybacks, dividends, interest, or take-outs rather than relying on investor revaluation. Many of their largest holdings offer double-digit returns directly to investors.	SYENS.BR VTRS ALIT VTSC.DE THC BKD CEIX GRBK	View

Pitches With This Ticker

Date	Pitch Type	Author	Company	Industry	Sub Industry	Bull / Bear	Stock Exchange	Keywords	Action
Apr 28, 2026	Fund Letters	Greenlight Capital	Alight	Information Technology	Human Resource & Employment Services	Bull	NYSE	AI, cloud, enterprise, HR Software, Private equity exit, recurring revenue, SaaS	View Pitch
Apr 28, 2026	Fund Letters	Polen Capital - Global SMID Company Growth	Alight	Information Technology	IT Consulting & Other Services	Bull	NYSE	BPaaS, cloud-based, Employee Engagement, margin of safety, Opportunistic, subscription growth, Workplace Benefits	View Pitch
Apr 28, 2026	Fund Letters	Polen Capital - U.S. Small Company Growth	Alight	Information Technology	Human Resource & Employment Services	Bull	NYSE	BPaaS, cloud-based, Employee Benefits, Hr Technology, Human Capital, Payroll Services, Workplace Solutions	View Pitch
Apr 13, 2026	Fund Letters	Aristotle Small/Mid Cap Equity	Alight	Information Technology	Software	Bull	NYSE	Benefits administration, cloud platform, Enterprise software, Fortune 500, Human capital management, Margin Improvement, SaaS	View Pitch
Apr 13, 2026	Fund Letters	Aristotle Small Cap Equity Fund	Alight	Information Technology	Software	Bull	NYSE	Benefits administration, cloud platform, Fortune 500, Hr Technology, Human capital management, margin expansion, SaaS	View Pitch
Apr 13, 2026	Fund Letters	Polen Capital - Global SMID Company Growth	Alight	Information Technology	Data Processing & Outsourced Services	Bull	NYSE	Cloud software, Employee Benefits, growth, Hr Technology, SaaS, technology, Workplace Tools	View Pitch
Apr 13, 2026	Fund Letters	Meridian Growth Fund	Alight, Inc.	Software & Services	IT Services	Bull	NYSE	Activist Investment, Automation, Cloud software, Cost efficiency, Enterprise software, HR Services, Human Capital Technology	View Pitch
Apr 13, 2026	Fund Letters	Meridian Small Cap Growth Fund	Alight, Inc.	Information Technology	IT Services	Bull	NYSE	Automation, cloud-based, Cost Reduction, Enterprise software, Hr Technology, Human Capital, SaaS	View Pitch
Dec 9, 2025	Substack	Toff Cap Monday Monitor	Alight Solutions	Information Technology	Software - Application	Bull		Alight Solutions, business services, cloud migration, deleveraging, EBITDA, efficiency gains, Free Cash Flow, insider buying, operational improvements, turnaround	View Pitch
Nov 29, 2025	Fund Letters	Chad Meade	Alight, Inc.	Information Technology	Data Processing & Outsourced Services	Bear	NYSE	Bookings, deleveraging, Execution, guidance, Outsourcing, Retention	View Pitch
Nov 29, 2025	Fund Letters	Chad Meade	Alight Inc.	Information Technology	Human Capital Software	Bear	NYSE	AI integration, Execution, HCM, Margin recovery, Retention, Software, transformation, valuation	View Pitch
Oct 23, 2025	Value Investors Club	Griffin	Alight Inc.	Information Technology	Human Resource & Employment Services	Bull	NYSE	Automation, Benefits administration, Buyback program, cloud migration, Dividend initiation, FCF growth, Human capital software, margin expansion, Starboard Value, turnaround	View Pitch

BSD Shareholders of ALIT

This report provides a detailed summary of investor holdings for a specified stock ticker, highlighting key metrics such as fund name, total assets under management (AUM), invested value, portfolio weight, and shares owned. It also tracks changes in share ownership during the last quarter, including the percentage of shares bought or sold and the percentage of outstanding shares owned. The data is generated using an API that processes investor holdings and calculates these values for each fund. This report helps investors and analysts monitor the stock positions of major funds, identify investment trends, and assess the influence of large investors on individual stocks.

Filing Date: September 30, 2025

Manager Name	Fund Name	Fund AUM	Invested Value	Portfolio Weight	Shares Owned	Shares Bought / Sold During Quarter	% Bought / Sold During Quarter	% of Shares Outstanding Owned
No investor data available.

ALIT

ALIT

Letters With This Ticker

Pitches With This Ticker

BSD Shareholders of ALIT

Join for free and get access to the buyside

Get insights from the world's most influential hedge fund investors direct to your inbox

Follow Us On: